Mutual of America Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-44,052
| Closed | -$3.68M | – | 1460 |
|
|
2024
Q4 | $3.68M | Sell |
44,052
-39
| -0.1% | -$3.26K | 0.04% | 605 |
|
|
2024
Q3 | $3.23M | Sell |
44,091
-413
| -0.9% | -$30.2K | 0.03% | 688 |
|
|
2024
Q2 | $3.05M | Sell |
44,504
-1,927
| -4% | -$132K | 0.03% | 707 |
|
|
2024
Q1 | $3.21M | Sell |
46,431
-3,771
| -8% | -$261K | 0.03% | 694 |
|
|
2023
Q4 | $3.6M | Sell |
50,202
-2,287
| -4% | -$164K | 0.04% | 626 |
|
|
2023
Q3 | $2.73M | Buy |
52,489
+6,789
| +15% | +$354K | 0.03% | 709 |
|
|
2023
Q2 | $2.89M | Buy |
45,700
+8,529
| +23% | +$540K | 0.03% | 747 |
|
|
2023
Q1 | $2.01M | Buy |
+37,171
| New | +$2.01M | 0.02% | 899 |
|
|
2022
Q4 | – | Sell |
-37,362
| Closed | -$1.74M | – | 1601 |
|
|
2022
Q3 | $1.74M | Buy |
+37,362
| New | +$1.74M | 0.02% | 908 |
|